Table 1.
Characteristic | N‐BPs untreated cohort | N‐BPS treated cohort |
---|---|---|
n | 63,185 | 63,185 |
Age (years), mean ± SD | 73.4 ± 10.7 | 73.4 ± 10.7 |
Male, n (%) | 4507 (7.1) | 4507 (7.1) |
Respiratory drugs, n (%) | 14321 (22.7) | 14321 (22.7) |
Respiratory hospitalization, n (%) | 5628 (8.9) | 5628 (8.9) |
Neoplasms, n (%) | 4918 (7.8) | 4918 (7.8) |
CV hospitalization, n (%) | 11704 (18.5) | 11704 (18.5) |
Antihypertensives, n (%) | 41804 (66.2) | 41804 (66.2) |
Statins, n (%) | 23830 (37.7) | 23830 (37.7) |
Antidiabetics, n (%) | 7376 (11.7) | 7376 (11.7) |
Antidepressants, n (%) | 11923 (18.9) | 11923 (18.9) |
Glucocorticoids, n (%) | 17950 (28.4) | 17950 (28.4) |
Other anti‐osteoporotic drugs, n (%) | 696 (1.1) | 696 (1.1) |
Antidiabetics included insulin treatment.
CV = cardiovascular; N‐BPs = amino‐bisphosphonates.